23 results
425
ADAP
Adaptimmune Therapeutics Plc
22 May 23
Business combination disclosure
7:01am
an admission of the legal necessity or materiality under applicable laws of any of the supplemental disclosures set forth herein. To the contrary, TCR2
8-K
ADAP
Adaptimmune Therapeutics Plc
22 May 23
Other Events
6:59am
of the legal necessity or materiality under applicable laws of any of the supplemental disclosures set forth herein. To the contrary, TCR2
10-K
2016 FY
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
expenses to conform the presentation to the current period.
The Company has assessed the materiality of the classification errors in accordance … with the SEC’s guidance on assessing materiality, Staff Accounting Bulletin No. 99, Materiality, and determined that the errors are quantitatively
S-4/A
te7br6s19 td
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
424B3
y783dlh jz
20 Apr 23
Prospectus supplement
4:32pm
S-4
wno5 xpxo
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
S-3ASR
1mb i4fg2wien
12 Jul 18
Automatic shelf registration
4:30pm
S-3ASR
p3v9a5 hvu6r4
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
0fk2xg8 7halurjxg90c
10 Aug 20
Automatic shelf registration
5:01pm
424B5
knp62cs3mshii5t
21 Jan 20
Prospectus supplement for primary offering
5:21pm
424B5
rmhutt
1 Jun 20
Prospectus supplement for primary offering
6:06am
424B5
kmsj1yjcts8e
22 Jan 20
Prospectus supplement for primary offering
5:31pm